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Comparing our post-mortems of central nervous system
(CNS) aspergillosis in childhood with the data recentlyTable 1 Post-mortem cases of CNS aspergillosis in childhooda
Age (years) Gender Underlying disease Additional infection(s) Neuropathological findings
2 M Liver transplantation CMV infection Aspergillus encephalitis
7 M T-cell leukemia None (CMV suspected) Necrotizing multi-focal
Aspergillus encephalitis
16 M High-risk T-ALL,
bone-marrow
transplantation
CMV pneumonia, oral
HSV infection
Gross intracerebral hemorrhagic,
mycotic encephalitis
M, male; CMV, cytomegalovirus; HSV, herpes simplex virus; T-ALL, T-cell acute lymphoblastic leukemia.
a Out of 129 post mortems investigated between 1990 and 2006; Institute of Neuropathology, Hamburg, Germany.reviewed by Dotis et al.,1 we noticed some points that
may be worth mentioning from the neuropathological point
of view.
The authors emphasize that CNS aspergillosis is a rare
condition with the majority of cases being diagnosed only
post-mortem. Our own data are in line with these observa-
tions. Out of 129 post-mortem investigations only three cases
with CNS aspergillosis were seen.
We observed all cases of mycoses in the context of a
severe underlying disease compromising the immune system
or with medical immunosuppression (Table 1).2 All patients
suffered from additional infections or were suspected to have
other infections, e.g., cytomegalovirus (CMV) and herpes
simplex virus (HSV).
The diagnosis of multiple infections in severely diseased
patients may be difficult because the symptoms of the
different disorders may overlap, be the same, or mask each
other.3,4 As a result, diagnosis may be delayed or wrong,
resulting in late or inadequate treatment.
Considering the reasons for increased survival found
by Dotis et al. in cases with CNS aspergillosis after 1990,
these may in part also be explained by improvements in
the treatment of the underlying diseases, the manage-
ment of additional infections, and improved intensive care
facilities.
Cerebral aspergillosis usually develops following hema-
togenous spread of the pathogen from its port of entry —
mainly the lungs. The classical neuropathological picture
is that of a focal hemorrhagic encephalitis (and basal
meningitis) presenting as granuloma-abscesses, necrotiz-
ing arteritis, and septic infarcts with extensive hemor-
rhage.4 Bleeding may be aggravated by disturbances in
blood coagulation as in leukemic patients.5 This may lead
to an acute life-threatening rise in intracranial pressure asin the 16-year-old boy in our cohort who died from gross
intracerebral hemorrhage.
The cause of death gives important information about
the interaction and significance of different disorders in a
complex illness and thus — from the pathological point of
view — would have been a valuable additional parameter to
be included in the review by Dotis et al.Conflict of interest: No conflict of interest to declare.
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